Skyrizi 150 MG/ML penml
Ended Awarded Last action
- Contract number
- SPE2DR26F63Y7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $31,605
Award facts
- Contract value 100% obligated
- $31,605.01 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $31,605.01 to AmerisourceBergen Drug Corp for the supply of Skyrizi 150 mg/ml pen medication. This firm fixed-price delivery order, awarded December 17, 2025, represents a non-competitive set-aside procurement and carries an ultimate completion date of December 18, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive $1 billion global pharmaceutical supply vehicle designated SPE2DX and extending through December 2026, which enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal medical vendor, particularly for military and veteran healthcare systems. The company has demonstrated extensive capability in fulfilling federal procurement requirements through multiple competitive awards with the Defense Logistics Agency, supplying specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across diverse therapeutic domains. This procurement supports the Defense Health Agency's ongoing pharmaceutical supply needs as part of DLA's broader effort to maintain consistent medical supply chains for military healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F63Y7?
SPE2DR26F63Y7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 17, 2025.
How much is contract SPE2DR26F63Y7 worth?
The government has obligated $31,605 on SPE2DR26F63Y7.
Is contract SPE2DR26F63Y7 an order under another contract?
Yes. SPE2DR26F63Y7 is a delivery order under SPE2DR25D3303, an indefinite delivery contract.
Was contract SPE2DR26F63Y7 competed?
The extent of competition for SPE2DR26F63Y7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award